
Quoin Pharmaceuticals Ltd (QNRX)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -2.09M | -2.78M | -2.26M | -2.13M | -2.22M | -2.46M | -2.14M | -2.53M |
税引前収入 | -2M | -2.6M | -2.11M | -1.93M | -2.05M | -2.33M | -1.97M | -2.35M |
純利益 | -2M | -2.6M | -2.11M | -1.93M | -2.05M | -2.33M | -1.97M | -2.35M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -1.67M | -2.78M | -2.26M | -2.13M | -2.22M | -2.46M | -2.14M | -2.53M |
EBITDA | -2.16M | -2.75M | -2.23M | -2.1M | -2.17M | -2.43M | -2.11M | -2.5M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 280k | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -15.94M | -24.43M | -29.25M | -22.33M | -1.67M | -6.06M | -9.26M | -9.38M |
税引前収入 | -15.32M | -28.22M | -20.11M | -16.81M | -2.1M | -21.46M | -9.38M | -8.69M |
純利益 | -15.32M | -28.22M | -20.11M | -16.81M | -2.1M | -21.46M | -9.45M | -8.69M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.142 | -0.235 | -0.154 | -0.075 | -0.005 | -0.006 | 0 | -8.793 |
EBIT | -15.94M | -24.43M | -29.25M | -22.33M | -1.67M | -6.06M | -9.26M | -9.38M |
EBITDA | -15.6M | -24.06M | -28.8M | -21.52M | -1.57M | -5.96M | -9.15M | -9.26M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約